Dopamine Agonist in Treatment of ADHD with Restless Legs Syndrome and ODD

J Gordon Millichap

doi:10.15844/pedneurbriefs-19-5-4

Dopamine Agonist in Treatment of ADHD with Restless Legs Syndrome and ODD

Pediatric Neurology Briefs

Volume 19 (2005): Issue 5

By: J Gordon Millichap

Open Access

|May 2005

Abstract

A 6-year-old male with attention deficit hyperactivity disorder who responded poorly to methylphenidate (MPH) was benefited following treatment with the dopamine agonist ropinirole, in a report from the Hopital Robert Debre, Paris, France.

References

Konofal E Arnulf I Lecendreux M Mouren MC Ropinirole in a child with attention-deficit hyperactivity disorder and restless legs syndrome Pediatr Neurol 2005 May 32 5 350 351 10.1016/j.pediatrneurol.2004.11.007 15866437
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-19-5-4 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 36 - 36

Published on: May 1, 2005

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Dopamine Agonist,

Restless Legs Syndrome,

Ropinirole

© 2005 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 19 (2005): Issue 5